Never Run Out Of Buyers To Sell To.

Established in 2015, Barty was committed to the R&D of vascular intervention including cardiovascular and peripheral system. Our product portfolio includes paclitaxel-eluting balloon catheter, introducer sheath, angiography catheter, guide catheter, SC/NC PTCA & PTA balloon catheters, etc. By far, we have got CE certification, ISO13485, free sale certification, dozens of patents on our products, and well recognized by domestic and overseas markets.
Annual Revenue$100M to $250M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.